Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

COVID-19 may harm male fertility and damage the reproductive system.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.